Categories: BuildingCareDataManagementPlatformWearables
Proton Intelligence is developing CKM™, an investigational continuous potassium monitoring platform for heart failure and kidney disease care.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.01.2025 | Seed | $6.95M | - |
Mentions in press and media 3
| Date | Title | Description |
| 02.01.2025 | Proton Intelligence Secures $6.95 Million to Revolutionize Potassium Monitoring | In the world of healthcare, timing is everything. A moment’s delay can mean the difference between life and death. Proton Intelligence, a Vancouver-based company, is stepping into this critical space with its groundbreaking Continuous Potas... |
| 02.01.2025 | Proton Intelligence Raises $6.95M in Seed Funding | Proton Intelligence Inc., a Vancouver, Canada-based developer of a continuous potassium monitoring (CKM™) platform, closed a $6.95m USD seed financing round.
Backers included SOSV, We Venture Capital, Tenmile, LongeVC, 15th Rock, Exor, and ... |
| - | Proton Intelligence | “Transforming Hyperkalemia Management in CKD & Heart Failure with Continuous Potassium Monitoring” |
Reviews 0
